BARR/NOVOPHARM APPEAL OF AZT PATENT DECISION
Executive Summary
BARR/NOVOPHARM APPEAL OF AZT PATENT DECISION appears to hinge on whether the D.C. circuit court finds that a New Bern, N.C. lower federal court inappropriately halted a jury trial prior to relevant testimony regarding a mouse retroviral test's ability to predict activity of Burroughs Wellcome's Retrovir (zidovudine) in humans. Oral arguments were heard in the case before D.C. federal circuit court judges Alan Lourie, Robert Mayer and Alvin Scholl on May 2. A ruling is not expected until mid-summer.